Home > Products > BCMA & CD3
> Anti-BCMA x Anti-CD3 Bispecific Antibody (IgG-IgG)
Anti-BCMA x Anti-CD3 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-020)
Anti-BCMA x Anti-CD3 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-BCMA and anti-CD3 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Multiple myeloma (MM) therapy.
There are currently no customer reviews or questions for Anti-BCMA x Anti-CD3 Bispecific Antibody (IgG-IgG) (BSIG-020). Click the button below to contact us or submit your feedback about this product.